Hastings David C is a director of Scynexis Inc.
Person profile
Roles
Address
Burnaby, British Columbia, Canada
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Arbutus Biopharma Corp
5 Feb 24
4
SCYNEXIS INC
23 Jun 23
4
SCYNEXIS INC
20 Jun 23
4
Arbutus Biopharma Corp
3 Feb 23
3
Vascular Biogenics Ltd.
3 Jan 23
4
Entasis Therapeutics Holdings Inc.
11 Jul 22
4
SCYNEXIS INC
22 Jun 22
4
Entasis Therapeutics Holdings Inc.
15 Feb 22
4
Arbutus Biopharma Corp
20 Jan 22
4
Entasis Therapeutics Holdings Inc.
19 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Feb 24 | ABUS Arbutus Biopharma | Common Shares | Sell | Dispose S | No | Yes | 2.3125 | 9,593 | 22.18 k | 181,907 |
1 Feb 24 | ABUS Arbutus Biopharma | Common Shares | Grant | Acquire A | No | No | 0 | 112,500 | 0.00 | 191,500 |
1 Feb 24 | ABUS Arbutus Biopharma | Stock Option Common Shares | Grant | Acquire A | No | No | 2.4 | 450,000 | 1.08 mm | 450,000 |
15 Jun 23 | SCYX Scynexis | Common Stock | Grant | Acquire A | No | No | 0 | 10,000 | 0.00 | 23,183 |
15 Jun 23 | SCYX Scynexis | Stock Option Common Stock | Grant | Acquire A | No | No | 2.74 | 10,000 | 27.40 k | 10,000 |
1 Feb 23 | ABUS Arbutus Biopharma | Common Shares | Grant | Acquire A | No | No | 0 | 79,000 | 0.00 | 79,000 |
1 Feb 23 | ABUS Arbutus Biopharma | Stock Option Common Shares | Grant | Acquire A | No | No | 2.9 | 316,000 | 916.40 k | 316,000 |